Long COVID's Rising Costs: An $8 Billion Crisis Ignored by U.S. Authorities
The quiet $8 billion crisis: long COVID costs keep rising as Washington looks away
Fortune
Image: Fortune
Long COVID, affecting over 44 million Americans, is projected to impose an economic burden exceeding $8 billion from 2025 to 2027. With 6%-20% of COVID-19 survivors developing long COVID symptoms, the costs stem primarily from lost productivity. Despite its growing impact, U.S. funding and support for long COVID research and treatment have diminished significantly.
- 01Long COVID symptoms can persist for over three months, affecting productivity and healthcare costs.
- 02The estimated annual cost of long COVID could range from $2.01 billion to $3.4 billion, depending on incidence rates.
- 03The economic burden of long COVID is projected to exceed $8 billion from 2025 to 2027, assuming a conservative 6% incidence rate.
- 04The U.S. Department of Health and Human Services closed the Office of Long COVID Research in 2025, indicating a lack of national strategy.
- 05Long COVID treatment options are limited, with a significant shortage of specialized clinics available to meet demand.
Advertisement
In-Article Ad
Long COVID, which affects over 44 million Americans, is projected to create an economic burden exceeding $8 billion from 2025 to 2027. This condition arises when COVID-19 symptoms, such as fatigue and shortness of breath, persist for more than three months. Research indicates that between 6% to 20% of individuals who contract COVID-19 may develop long COVID, leading to significant healthcare costs and productivity losses. The estimated annual costs could range from $2.01 billion to $3.4 billion, depending on the prevalence of long COVID cases. The longer symptoms persist, the higher the overall costs, with productivity losses accounting for over 90% of these expenses. Despite the growing crisis, U.S. funding for long COVID research has diminished, including the closure of the Office of Long COVID Research in 2025. The lack of effective treatments and a national strategy to address long COVID further exacerbates the situation, leaving many individuals without adequate support. As the number of long COVID cases continues to rise, the economic implications for society are substantial, emphasizing the urgent need for renewed focus and resources to tackle this ongoing health crisis.
Advertisement
In-Article Ad
The rising costs associated with long COVID will likely affect employers and the economy due to increased healthcare expenses and reduced workforce productivity.
Advertisement
In-Article Ad
Reader Poll
Should the government allocate more resources to long COVID research?
Connecting to poll...
More about Department of Health and Human Services
Read the original article
Visit the source for the complete story.




